LNDZF OTC
Evome Medical Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -97.6%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$919K
+0.0% ▲
Capital Expenditures
$203K
+0.0% ▲
5Y CAGR: +17.0%
Free Cash Flow
-$1M
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$761K | -$2M | -$3M | -$4M | -$16M |
| Depreciation & Amort. | $256K | $55K | $842K | $842K | $2M |
| Stock-Based Comp. | $96K | $22K | $1M | $1M | $1M |
| Change in Working Capital | $4M | $1M | $1M | -$206K | -$925K |
| Other Non-Cash Items | $62K | $269K | -$544K | -$1M | $12M |
| Operating Cash Flow | $4M | -$128K | -$975K | -$4M | -$919K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$55K | -$55K | -$203K |
| Acquisitions (Net) | $0 | $0 | -$5M | -$5M | -$1M |
| Investment Purchases | $0 | -$899K | -$370K | $0 | $0 |
| Investment Sales | $0 | $0 | $445K | $497K | $0 |
| Other Investing | $0 | $0 | $5M | $0 | $0 |
| Investing Cash Flow | $0 | -$899K | $75K | -$5M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$44K | $791K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $5M | -$283K | $34K |
| Financing Cash Flow | $0 | $0 | $5M | $4M | $825K |
| Net Change in Cash | $3M | -$954K | $4M | -$4M | -$1M |
| Cash End of Period | $9M | $8M | $13M | $8M | $919K |
| Free Cash Flow | $4M | -$128K | -$1M | -$4M | -$1M |